Skyquest Logo
Precision Medicine Market to Surpass USD 75.30 Billion by 2031 | Skyquest Technology
12 juil. 2024 09h05 HE | SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, July 12, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the global precision medicine market will attain a value of USD 75.30 billion by 2031, with a CAGR of 11.4% during the...
IMAC Holdings, Inc. Appoints Dr. Matthew Schwartz and Dr. Peter Beitsch to Board of Directors
11 juil. 2024 09h21 HE | IMAC Holdings, Inc.
Golden, CO, July 11, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (NASDAQ: BACK) (the “Company” or “IMAC”), a leading innovator in proteomics research and technology, announced the appointment of...
Sarma1 2
STALICLA appoints Dr. Purnanand Sarma, PhD, as Chair of the Board of Directors
09 juil. 2024 07h00 HE | STALICLA
Press Release Dr. Sarma brings exceptional expertise in all facets of the pharmaceutical and biotechnology business, from scaling platforms to developing therapeutics Geneva, Switzerland – July 9,...
Global Genotyping Assay Market
Global Genotyping Assay Market Research and Forecasts to 2029
02 juil. 2024 10h11 HE | Research and Markets
Dublin, July 02, 2024 (GLOBE NEWSWIRE) -- The "Global Genotyping Assay Market by Product & Services (Kits, Instruments,Bioinformatics), Technology (PCR, Sequencing, Microarray), Application...
DMR Logo.png
Personalized Medicine Biomarker Market Size to Reach USD 72.7 Billion By 2033, at 17.5 CAGR: Insights by Dimension Market Research
01 juil. 2024 11h34 HE | Dimension Market Research
New York, July 01, 2024 (GLOBE NEWSWIRE) -- Overview The global Personalized Medicine Biomarker Market size is expected to reach USD 17.0 billion by 2024 and it is further anticipated to reach...
Registrations Open for the 2024 Orphan Drugs and Rare Diseases Conference - Boston, MA, United States - October 17-18th, 2024
28 juin 2024 10h26 HE | Research and Markets
Dublin, June 28, 2024 (GLOBE NEWSWIRE) -- The "Orphan Drugs and Rare Diseases" conference has been added to's offering. The 2 day Orphan Drugs and Rare Diseases Conference...
Nucleic Acid Therapeutics CDMO Market Research Report 2024-2034 Featuring Strategic Analysis of Lonza Group, Catalent, and Thermo Fisher Scientific Among Others
28 juin 2024 10h23 HE | Research and Markets
Dublin, June 28, 2024 (GLOBE NEWSWIRE) -- The "Global Nucleic Acid Therapeutics CDMO Market" report has been added to's offering.The global nucleic acid therapeutics CDMO...
Genome Editing Technologies Market Report 2024-2034 - Emerging Economies Projected to Boost Industry Growth
27 juin 2024 07h20 HE | Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Genome Editing Technologies Market Report 2024-2034" has been added to's offering.World revenue for the Genome Editing...
Stalilcla logo.png
STALICLA publishes pioneering phase 1b data on precision treatment for autism spectrum disorder in Biomedicines
27 juin 2024 07h10 HE | STALICLA
Press Release STALICLA’s precision psychiatry study highlights strong EEG-based target engagement of STP1 treatment in defined subgroup of patients with autism and numerical improvement in core...
Proscia-Nucleai Logo.jpg
Proscia And Nucleai Partner To Broaden Access To AI Predictive Biomarkers
25 juin 2024 08h00 HE | Proscia
PHILADELPHIA and CHICAGO, June 25, 2024 (GLOBE NEWSWIRE) -- Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, has partnered with Nucleai, a leading spatial AI...